Breast Microseed Treatment®, by Concure Oncology®, is a one-time, one-hour treatment for early stage breast cancer.
Concure Oncology/Breast Microseed, Inc. specializes in early-stage breast cancer treatment and related services. The Company provides the technology, protocol, and equipment used by medical partners to perform Breast Microseed Treatment (BMT), its early-stage, post lumpectomy breast cancer procedure. BMT offers efficacy and outcomes equivalent to other radiation treatments for early stage breast cancer, post-lumpectomy, but with milder and less frequent side effects. Because it’s administered in a one-time, one-hour procedure, a quicker, simpler return to health and wellness becomes possible. Breast Microseed is committed to easing the burden for women facing early-stage breast cancer by enhancing and simplifying radiation treatment so they can get back to living their lives.
Concure Oncology is committed to easing the burden for women facing early-stage breast cancer by enhancing and simplifying radiation treatment so they can get back to living their lives.
